MilliporeSigma
  • Multiple mechanisms of ligand interaction with the human organic cation transporter, OCT2.

Multiple mechanisms of ligand interaction with the human organic cation transporter, OCT2.

American journal of physiology. Renal physiology (2012-10-05)
Jaclyn N Harper, Stephen H Wright
ABSTRACT

OCT2 is the entry step for organic cation (OC) secretion by renal proximal tubules. Although many drugs inhibit OCT2 activity, neither the mechanistic basis of their inhibition nor their transport status is generally known. Using representatives of several structural classes of OCT2-inhibitory ligands described recently (Kido Y, Matsson P, Giacomini KM. J Med Chem 54: 4548-4558, 2011), we determined the kinetic basis of their inhibition of 1-methyl-4-phenylpyridinium (MPP) transport into Chinese hamster ovary cells that stably expressed hOCT2. The "cluster II" inhibitors (which contain known OCT2 substrates) metformin and cimetidine interacted competitively with MPP. However, other cluster II compounds, including tetraethylammonium (TEA), diphenidol and phenyltoloxamine, were mixed-type inhibitors of MPP transport (i.e., decreasing J(max) and increasing K(t)). A cluster III (neutral steroid) representative, adrenosterone, and a cluster I (large, flexible cation) representative, carvedilol, displayed noncompetitive inhibitory profiles. Competitive counterflow (CCF) was used to determine whether the inhibitory ligands served as substrates of hOCT2. Carvedilol (cluster I) and adrenosterone (cluster III) did not support CCF, consistent with the prediction that members of these structural classes are likely to be nontransported inhibitors of OCT2. The cluster II representatives MPP, metformin, cimetidine, and TEA all supported CCF, consistent with independent assessments of their OCT2-mediated transport. However, the other cluster II representatives, diphenidol and phenyltoloxamine, failed to support CCF, suggesting that neither compound is transported by OCT2. An independent assessment of diphenidol transport (using liquid chromatography with tandem mass spectroscopy) confirmed this observation. The results underscore the caution required for development of predictive models of ligand interaction with multidrug transporters.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Cimetidine
Sigma-Aldrich
Adrenosterone, 98%
Supelco
Cimetidine, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Tetraethylammonium chloride hydrate
Sigma-Aldrich
Tetraethylammonium iodide, 98%
Sigma-Aldrich
Tetraethylammonium chloride, ≥98% (titration)
Supelco
Tetraethylammonium chloride, for electrochemical analysis, ≥99.0%
Sigma-Aldrich
Tetraethylammonium hydroxide solution, ~25% in methanol (~1.5 M)
Supelco
Tetraethylammonium hydroxide solution, ~1.0 M (CH3CH2)4NOH in H2O, electrochemical grade
Sigma-Aldrich
Tetraethylammonium hydroxide solution, 20 wt. % in H2O
Sigma-Aldrich
Tetraethylammonium bromide, ReagentPlus®, 99%
Sigma-Aldrich
Tetraethylammonium bromide, reagent grade, 98%
Sigma-Aldrich
Tetraethylammonium hydroxide solution, 35 wt. % in H2O
Sigma-Aldrich
Tetraethylammonium chloride, BioUltra, for molecular biology, ≥99.0% (AT)